Preclinical approaches in chronic myeloid leukemia: from cells to systems

Advances in the design of targeted therapies for the treatment of chronic myeloid leukemia (CML) have transformed the prognosis for patients diagnosed with this disease. However, leukemic stem cell persistence, drug intolerance, drug resistance, and advanced-phase disease represent unmet clinical ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Cassie J., Holyoake, Tessa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Inc 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333535/
https://www.ncbi.nlm.nih.gov/pubmed/28017647
http://dx.doi.org/10.1016/j.exphem.2016.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333535/
https://www.ncbi.nlm.nih.gov/pubmed/28017647
http://dx.doi.org/10.1016/j.exphem.2016.11.005

Ejemplares similares